Blaire Cooke

Pharmacokinetics and tissue distribution of betulinic acid in CD‐1 mice 1

J. Pezzuto, A. Kinghorn, G. Udeani, 1999, Biopharmaceutics & drug disposition.

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

A. Shaywitz, M. Retter, E. Stein, 2012, Journal of the American College of Cardiology.

Treatment of systemic lupus erythematosus patients with the BAFF antagonist “peptibody” blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials

M. Weisman, E. Rasmussen, J. Ferbas, 2015, Arthritis Research & Therapy.

Pharmacokinetics and safety of neratinib during co-administration with loperamide in healthy subjects

Jane Liang, I. Rubets, E. Olek, 2019, Cancer Chemotherapy and Pharmacology.

EFFECTS OF AMG 145, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST PCSK9, ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN SUBJECTS TAKING STATINS: A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ASCENDING MULTIPLE-DOSE STUDY

A. Shaywitz, E. Stein, J. Gibbs, 2012 .

An Extended Terminal Half-Life for Darbepoetin Alfa

D. Padhi, G. Jang, Liyun Ni, 2006, Clinical pharmacokinetics.

Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins.

A. Shaywitz, M. Retter, E. Stein, 2012, Journal of the American College of Cardiology.